Dry Eye Disease: Current and Emerging Novel Tear Stimulating Therapies for Improved Outcomes

Learning Objectives

Upon completion of the educational activity, participants should be able to:

• Summarize the pathophysiology and factors contributing to DED, such as preservatives in topicals, refractive or cataract surgery, menopause, and autoimmune diseases
• Assess real-world evidence surrounding available and new tear-stimulating therapies to improve patient outcomes of individuals with DED

Accredited Providers

This activity is provided by Amedco and MedNet.

   

Joint Accreditation Statement

In support of improving patient care, Amedco and MedNet have planned and implemented this activity. Amedco is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. MedNet serves as the content and logistic provider for this activity. Amedco designates this activity for 1.25 AMA PRA Category 1 Credits^TM

Physicians Credit Designation

Amedco designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Additional Credit Information

Note to Physician Assistants
AAPA accepts AMA PRA Category 1 Credit^TM for the PRA from organizations accredited by ACCME. Maximum of 1.25 hours.

Note to Nurse Practitioners
The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors, and allows reciprocity for AANPCP continuing education credit. Maximum of 1.25 hours.

Through an agreement between the American Medical Association (AMA) and the European Union of Medical Specialists, physicians and healthcare providers may convert CME/CE PRA Category 1 Credits^TM to an equivalent number of European CME Credits^® (ECMECs^®). The UEMS-EACCME^® has recognition agreements with the AMA for live events and e-learning materials.

Faculty

>

Neal Guymon, OD
Optometrist
Summit EyeCare
Idaho Falls, ID

Dr. Guymon discloses the following:
Content Creator: TearRestore Inc. and Danelli Ocular Creations; Affiliate for Danelli Ocular Creations

Eric D. Donnefeld, MD
Clinical Professor of Ophthalmology
New York University Langone Medical Center
Ophthalmic Consultants of Long Island
New York, NY

Dr. Donnefeld discloses the following:
Speaker: Allegro, Abbvie, Alcon, AVTRMed, Aurion, Bausch & Lomb, CorneaGen, Covalent, CRST, Crystilex, BVI, Blephex, ELT Sight, EyePoint Pharma, Foresight, Glaukos, Horizon Surgical Systems, Inversa, Johnson & Johnson, Kala, Katena, Lacripen, LayerBio, LensGen, Mati Pharmaceuticals, Melt Pharmaceuticals, MDBackline, MOA, Nordic Pharma, Novabay, Ocular Innovations, Oculis, Omega Ophthalmics, Ocuhub, PRN, Rayner, ReTear, Singular, Strathspey Crown, Surface, Tarsus, Tearscience, Tenpoint Pharma, Versant Ventures, Visionary Venture, and Zeiss

Instructions

In order to receive CME/CE credits, participants must complete the pre-assessment questions, post-assessment, and program evaluation. Participants must also score at least 75% on the post-assessment. Certificates will be distributed online at the conclusion of the activity. Your online certificate will be saved on myCME within your Dashboard or Transcript, which you can access at any time.

ACCME – Amedco
Phone Number: 651-789-3730
E-Mail: justin@amedcoemail.com

Privacy Policy

myCME privacy policy